$CTV
Innovid Corp. Stock $ctv

$ctv Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000183537823000070 Filed on May 09, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$34.55M	$30.49M	$25.86M
YoY Change	4.41%	17.88%	43.57%
Cost Of Revenue	$8.591M	$8.265M	$6.344M
YoY Change	16.87%	30.28%	64.27%
Gross Profit	$25.96M	$22.22M	$19.52M
YoY Change	0.85%	13.84%	37.93%
Gross Profit Margin	75.13%	72.89%	75.47%
Selling, General & Admin	$20.38M	$21.29M	$21.99M
YoY Change	-16.03%	-3.18%	143.15%
% of Gross Profit	78.54%	95.8%	112.64%
Research & Development	$6.876M	$7.117M	$7.329M
YoY Change	-29.19%	-2.89%	38.36%
% of Gross Profit	26.49%	32.03%	37.55%
Depreciation & Amortization	$2.064M	$2.030M	$673.0K
YoY Change	122.89%	201.63%	269.78%
% of Gross Profit	7.95%	9.14%	3.45%
Operating Expenses	$27.26M	$28.40M	$29.32M
YoY Change	-19.79%	-3.11%	104.44%
Operating Profit	-$17.87M	-$8.214M	-$9.797M
YoY Change	94.81%	-16.16%	5111.17%
Interest Expense	$248.0K	$2.475M	$2.311M
YoY Change	-98.14%	7.1%	-247.29%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$17.62M	-$5.739M	-$7.486M
YoY Change	-526.52%	-23.34%	326.07%
Income Tax	$1.335M	$2.824M	-$37.00K
% Of Pretax Income
Net Earnings	-$18.96M	-$8.563M	-$7.449M
YoY Change	-540.91%	14.96%	284.76%
Net Earnings / Revenue	-54.88%	-28.09%	-28.8%
Basic Earnings Per Share	-$0.14	-$0.06	-$0.06
Diluted Earnings Per Share	-$0.14	-$0.06	-$0.06
COMMON SHARES
Basic Shares Outstanding	137.2M shares	136.3M shares	124.2M shares
Diluted Shares Outstanding	137.6M shares	136.0M shares	124.2M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$43.38M	$45.02M	$45.44M
YoY Change	-1.45%	-0.94%	6993.17%
Cash & Equivalents	$43.38M	$45.02M	$45.44M
Short-Term Investments
Other Short-Term Assets	$4.123M	$5.692M	$6.571M
YoY Change	-21.42%	-13.38%	748.58%
Inventory
Prepaid Expenses
Receivables	$43.24M	$39.95M	$38.77M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$90.75M	$90.65M	$90.78M
YoY Change	-2.24%	-0.14%	4915.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$18.96M	$16.97M	$6.599M
YoY Change	113.94%	157.13%
Goodwill	$102.5M	$117.0M	$97.20M
YoY Change	-10.59%	20.34%
Intangibles	$27.66M	$28.79M	$59.27M
YoY Change	-21.28%	-51.42%
Long-Term Investments	$260.0K	$265.0K	$303.0K
YoY Change	-16.67%	-12.54%	-99.88%
Other Assets	$834.0K	$813.0K	$542.0K
YoY Change	33.44%	50.0%
Total Long-Term Assets	$152.6M	$166.7M	$167.9M
YoY Change	-6.4%	-0.71%	-33.66%
TOTAL ASSETS
Total Short-Term Assets	$90.75M	$90.65M	$90.78M
Total Long-Term Assets	$152.6M	$166.7M	$167.9M
Total Assets	$243.3M	$257.3M	$258.6M
YoY Change	-4.89%	-0.51%	1.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.421M	$4.919M	$3.791M
YoY Change	20.76%	29.75%
Accrued Expenses	$5.194M	$7.166M	$4.183M
YoY Change	11.41%	71.31%	730.36%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$6.000M
YoY Change
Total Short-Term Liabilities	$22.20M	$23.84M	$25.81M
YoY Change	-35.68%	-7.64%	5024.27%
LONG-TERM LIABILITIES
Long-Term Debt	$20.00M	$20.00M	$0.00
YoY Change
Other Long-Term Liabilities	$9.461M	$8.024M	$10.47M
YoY Change	146.96%	-23.37%	-74.03%
Total Long-Term Liabilities	$31.56M	$30.96M	$29.91M
YoY Change	238.63%	3.51%	-25.83%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.20M	$23.84M	$25.81M
Total Long-Term Liabilities	$31.56M	$30.96M	$29.91M
Total Liabilities	$53.76M	$54.80M	$55.72M
YoY Change	22.66%	-1.65%	36.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$178.4M	-$159.4M	-$139.9M
YoY Change	31.55%	13.95%
Common Stock	$13.00K	$13.00K	$13.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$189.6M	$202.5M	$202.9M
YoY Change
Total Liabilities & Shareholders Equity	$243.3M	$257.3M	$258.6M
YoY Change	-4.89%	-0.51%	1.5%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$18.96M	-$8.563M	-$7.449M
YoY Change	-540.91%	14.96%	284.76%
Depreciation, Depletion And Amortization	$2.064M	$2.030M	$673.0K
YoY Change	122.89%	201.63%	269.78%
Cash From Operating Activities	$580.0K	$368.0K	-$7.213M
YoY Change	-106.68%	-105.1%	-240.41%
INVESTING ACTIVITIES
Capital Expenditures	$2.600M	$89.00K	$97.00K
YoY Change	-232.05%	-8.25%	-40.85%
Acquisitions		$0.00	$99.57M
YoY Change		-100.0%
Other Investing Activities	$20.00K	$10.01M	-$99.57M
YoY Change	-31.03%	-110.05%	-905236.36%
Cash From Investing Activities	-$2.580M	$6.827M	-$101.3M
YoY Change	32.99%	-106.74%	66130.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$5.000M	$0.00
YoY Change
Cash From Financing Activities	364.0K	$250.0K	-$2.718M
YoY Change	-96.03%	-109.2%	-1610.0%
NET CHANGE
Cash From Operating Activities	580.0K	$368.0K	-$7.213M
Cash From Investing Activities	-2.580M	$6.827M	-$101.3M
Cash From Financing Activities	364.0K	$250.0K	-$2.718M
Net Change In Cash	-1.636M	$7.445M	-$111.3M
YoY Change	12.13%	-106.69%	-2254.61%
FREE CASH FLOW
Cash From Operating Activities	$580.0K	$368.0K	-$7.213M
Capital Expenditures	$2.600M	$89.00K	$97.00K
Free Cash Flow	-$2.020M	$279.0K	-$7.310M
YoY Change	-69.94%	-103.82%	-246.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001835378
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-40048
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Innovid Corp.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-3769599
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	30 Irving Place,
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	12th Floor
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10003
CY2023Q1	dei	City Area Code CityAreaCode	212
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	966-7555
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	137195478	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45015000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37541000	usd
CY2023Q1	iacb	Short Term Bank Deposit Current ShortTermBankDepositCurrent	0	usd
CY2022Q4	iacb	Short Term Bank Deposit Current ShortTermBankDepositCurrent	10000000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	155000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	65000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39945000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	43653000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5692000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2640000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1347000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	90652000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	93834000	usd
CY2023Q1	iacb	Long Term Other Deposit LongTermOtherDeposit	265000	usd
CY2022Q4	iacb	Long Term Other Deposit LongTermOtherDeposit	277000	usd
CY2023Q1	iacb	Long Term Restricted Deposit LongTermRestrictedDeposit	401000	usd
CY2022Q4	iacb	Long Term Restricted Deposit LongTermRestrictedDeposit	430000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16968000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14322000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	116976000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	116976000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	28788000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	29918000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2450000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2910000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	813000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	938000	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	166661000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	165771000	usd
CY2023Q1	us-gaap	Assets Assets	257313000	usd
CY2022Q4	us-gaap	Assets Assets	259605000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4919000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3361000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9867000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10165000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1891000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2186000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7166000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5474000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	23843000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21186000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	20000000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	20000000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1636000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8024000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6554000	usd
CY2023Q1	iacb	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	1587000	usd
CY2022Q4	iacb	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	4301000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	30958000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	32491000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	54801000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	53677000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	136616734	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	136616734	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	133882414	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	133882414	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	13000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	13000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	361948000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	356801000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-159449000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-150886000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	202512000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	205928000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	257313000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	259605000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30485000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25862000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	8265000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	5926000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7117000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7254000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11637000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10351000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9650000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11455000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2030000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	673000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8214000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9797000	usd
CY2023Q1	iacb	Finance Income Expenses Net FinanceIncomeExpensesNet	-2475000	usd
CY2022Q1	iacb	Finance Income Expenses Net FinanceIncomeExpensesNet	-2311000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5739000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7486000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2824000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-37000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-8563000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7449000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8563000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8563000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-7449000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7449000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	136008998	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	136008998	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	124245358	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	124245358	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	161255000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	47152000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1496000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	462000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7449000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	202916000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	205928000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4897000	usd
CY2023Q1	iacb	Share Based Compensation Arrangement By Share Based Payment Award Stock Options Exercised And Restricted Stock Units Vested In Period Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOptionsExercisedAndRestrictedStockUnitsVestedInPeriodValue	250000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-8563000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	202512000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-8563000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7449000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2030000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	673000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4533000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1496000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2714000	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2787000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3708000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-163000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2922000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1950000	usd
CY2023Q1	iacb	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	459000	usd
CY2022Q1	iacb	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	431000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1558000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-191000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-299000	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1704000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-584000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-410000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	5000000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	3162000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1107000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	368000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7213000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	99568000	usd
CY2023Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	3091000	usd
CY2022Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1671000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	89000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	97000	usd
CY2023Q1	iacb	Withdrawal Of Short Term Bank Deposits WithdrawalOfShortTermBankDeposits	-10000000	usd
CY2022Q1	iacb	Withdrawal Of Short Term Bank Deposits WithdrawalOfShortTermBankDeposits	0	usd
CY2023Q1	iacb	Proceeds From Payments For Deposits Investing Activities ProceedsFromPaymentsForDepositsInvestingActivities	7000	usd
CY2022Q1	iacb	Proceeds From Payments For Deposits Investing Activities ProceedsFromPaymentsForDepositsInvestingActivities	3000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6827000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-101333000	usd
CY2022Q1	iacb	Noncash Or Part Noncash Acquisition Equity Instrument Consideration Equity Issued NoncashOrPartNoncashAcquisitionEquityInstrumentConsiderationEquityIssued	47152000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45015000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	362000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	61000	usd
CY2023Q1	iacb	Noncash Or Part Noncash Acquisition Equity Instrument Consideration Equity Issued NoncashOrPartNoncashAcquisitionEquityInstrumentConsiderationEquityIssued	0	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5000000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2023Q1	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	0	usd
CY2022Q1	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	3180000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	250000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	462000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	250000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2718000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7445000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-111264000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37971000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	157158000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45416000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45894000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	203000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	165000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45441000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	401000	usd
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	453000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45416000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45894000	usd
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prior period reclassification:</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2022 we began presenting depreciation and amortization expenses as a separate line item on our condensed consolidated statements of operations and all prior periods have been adjusted. Depreciation and amortization expenses were previously included in cost of sales and other operating expenses depending on the underlying asset’s function. Additionally, we no longer present gross profit as a subtotal on our condensed consolidated statements of operations. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reclassification is intended to better reflect the financial performance of transactions with customers as our business has evolved including our most recent acquisition of TVS. The change is intended to provide more clarity about changes in cost of revenue and other operating expenses exclusive of depreciation and amortization, and better align with how our peers and competitors present their financial statements. </span></div>In accordance with US GAAP, all periods presented below have been retrospectively adjusted to reflect the reclassification of cost of revenue and other operating expenses exclusive of depreciation and amortization. There was no net impact to loss from operations, net loss attributable to common stockholders or net loss per stock for any periods presented. The condensed consolidated balance sheets, condensed statements of changes in temporary equity and stockholders’ equity, and the condensed consolidated statements of cash flows are not affected by this reclassification.
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	8265000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	5926000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7117000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7254000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11637000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10351000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9650000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11455000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2030000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	673000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	Use of EstimatesThe preparation of the condensed consolidated financial statements in conformity with US GAAP requires management to make estimates, judgments, and assumptions. The Company’s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
CY2023Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q1	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingunit
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of credit risks</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, deposits and trade receivables, net. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of the Company’s cash and cash equivalents are invested in deposits with major banks in US and Israel. The Company is exposed to credit risk in the event of default by the financial institutions to the extent of the amounts recorded on the accompanying consolidated balance sheets exceed federally insured limits. Generally, these investments may be redeemed upon demand and, therefore, bear minimal risk.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2023, Si</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">licon Valley Bank (“SVB”)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, where the Company maintains an operating account with a cash balance of $32,571 of the Company's total cash, cash equivalents, was closed by the California Department of Financial Protection and Innovation and the FDIC was appointed as receiver. On March 12, 2023, the U.S. Department of the Treasury, Federal Reserve Board, and FDIC released a joint statement announcing that the FDIC would complete its resolution of SVB in a manner that fully protected all depositors at SVB and that depositors would have access to all of their money starting March 13, 2023. On March 27, 2023 First Citizens BancShares, Inc. announced, that it has entered into an agreement with the Federal Deposit Insurance Corporation (FDIC) to purchase all of the assets and liabilities of Silicon Valley Bridge Bank, N.A. Due to these actions the Company does not believe that it has exposure to loss as a result of SVB’s receivership.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s trade receivables, net is mainly derived from sales to customers located in the US, APAC, EMEA, and LATAM. The Company mitigates its credit risks by performing an ongoing credit evaluations of its customers’ financial conditions.</span></div>The Company has no off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.
CY2023Q1	iacb	Revenue From Contract With Customer Payment Term RevenueFromContractWithCustomerPaymentTerm	P60D
CY2023Q1	iacb	Revenue Recognition Advertisement Serving Services Percentage RevenueRecognitionAdvertisementServingServicesPercentage	0.730
CY2022Q1	iacb	Revenue Recognition Advertisement Serving Services Percentage RevenueRecognitionAdvertisementServingServicesPercentage	0.851
CY2023Q1	iacb	Revenue Recognition Measurement Serving Percentage RevenueRecognitionMeasurementServingPercentage	0.230
CY2022Q1	iacb	Revenue Recognition Measurement Serving Percentage RevenueRecognitionMeasurementServingPercentage	0.103
CY2023Q1	iacb	Revenue Recognition Creative Serving Percentage RevenueRecognitionCreativeServingPercentage	0.039
CY2022Q1	iacb	Revenue Recognition Creative Serving Percentage RevenueRecognitionCreativeServingPercentage	0.043
CY2023Q1	iacb	Business Combination Compensation Arrangement Percentage BusinessCombinationCompensationArrangementPercentage	0.27
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2450000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3238000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2910000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.480
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3822000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	463000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	475000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	263000	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	82000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	21000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	4000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	747000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	561000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.031
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	523000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	574000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1657000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	989000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	651000	usd
CY2023Q1	iacb	Lessee Operating Lease Liability Undiscounted Lease Payments LesseeOperatingLeaseLiabilityUndiscountedLeasePayments	3297000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	59000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3238000	usd
CY2023Q1	iacb	Fractional Shares Issued Upon Exercise FractionalSharesIssuedUponExercise	0	shares
CY2023Q1	iacb	Threshold Period For Not To Transfer Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination ThresholdPeriodForNotToTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination	P30D
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	5000000	usd
CY2023Q1	iacb	Bank Guarantees In Connection With Office Lease Agreement BankGuaranteesInConnectionWithOfficeLeaseAgreement	231000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	365000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	117000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	152000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	4600000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y1M2D
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2824000	usd
CY2022Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	37000	usd
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.005
CY2023Q1	iacb	Effective Income Tax Rate Discrete Items Percent EffectiveIncomeTaxRateDiscreteItemsPercent	0.067
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.547
CY2022Q1	iacb	Effective Income Tax Rate Discrete Items Percent EffectiveIncomeTaxRateDiscreteItemsPercent	0.002
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.007
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30485000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25862000	usd
CY2023Q1	us-gaap	Noncurrent Assets NoncurrentAssets	19418000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	17232000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-8563000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7449000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8563000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8563000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-7449000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7449000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	136008998	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	136008998	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	124245358	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	124245358	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06

Files In Submission

Name	View Source	Status
iacb-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001835378-23-000070-index-headers.html	Edgar Link	pending
0001835378-23-000070-index.html	Edgar Link	pending
0001835378-23-000070.txt	Edgar Link	pending
0001835378-23-000070-xbrl.zip	Edgar Link	pending
exhibit311q12023.htm	Edgar Link	pending
exhibit312q12023.htm	Edgar Link	pending
exhibit321q12023.htm	Edgar Link	pending
exhibit322q12023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
iacb-20230331.htm	Edgar Link	pending
iacb-20230331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
iacb-20230331_def.xml	Edgar Link	unprocessable
iacb-20230331_lab.xml	Edgar Link	unprocessable
iacb-20230331_pre.xml	Edgar Link	unprocessable
iacb-20230331_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CTV
Innovid Corp. Stock $ctv

2023 Q2 Form 10-Q Financial Statement

#000183537823000070 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTV Innovid Corp. Stock $ctv

2023 Q2 Form 10-Q Financial Statement

#000183537823000070 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTV
Innovid Corp. Stock $ctv